Skip to main content
Top

Drugs

Issue 15/2007

Content (14 Articles)

Role of HMG-CoA Reductase Inhibitors in Neurological Disorders

  • Current Opinion

Allison B. Reiss, Elzbieta Wirkowski

Recent Advances in the Pharmacological Management of Pain

  • Leading Article

Josée Guindon, Jean-Sébastien Walczak, Pierre Beaulieu

Modern Management of Small-Cell Lung Cancer

  • Therapy in Practice

Roberta Ferraldeschi, Sofia Baka, Babita Jyoti, Corinne Faivre-Finn, Nick Thatcher, Paul Lorigan

Treatment of Acute Lymphoblastic Leukaemia

  • Review Article

Effrosyni Apostolidou, Ronan Swords, Yesid Alvarado, Francis J. Giles

Current Management Strategies for Intraocular Retinoblastoma

  • Review Article

Jonathan W. Kim, David H. Abramson, Ira J. Dunkel

Topical Imiquimod

  • Adis Drug Evaluation

Antona J. Wagstaff, Caroline M. Perry

Deferasirox

  • Adis Drug Evaluation

Lily P. H. Yang, Susan J. Keam, Gillian M. Keating

Topiramate

  • Adis Drug Evaluation

Katherine A. Lyseng-Williamson, Lily P. H. Yang

Trabectedin

  • Adis Drug Evaluation

Natalie J. Carter, Susan J. Keam

Maraviroc

  • Adis Drug Profile

Natalie J. Carter, Gillian M. Keating

Maraviroc

  • Adis Drug Profile

Mark Nelson

Maraviroc

  • Adis Drug Profile

Jacob Lalezari

Maraviroc

  • Adis Drug Profile

Gerd Fätkenheuer

Pharmacological Neuroprotection for Glaucoma

  • Correspondence

Gábor Holló

Keynote webinar | Spotlight on dry eye disease

  • Live
  • Webinar | 28-05-2026 | 13:00 (CEST)

DED is highly prevalent yet challenging to diagnose and treat. Join leading experts to explore the latest developments and gain practical guidance on effective management in busy clinical settings. Brought to you by Springer Medicine and Eye.

Watch it live: 28 May 2026, 13:00–14:00 (CEST)

Prof. Harminder Dua
Prof. Sajjad Ahmad
Prof. Anat Galor
Join the webinar
Webinar
Image Credits
Conceptual illustration of dry eye disease/© Science Photo Library / Getty Images